Chemically induced intracellular hyperthermia

Details for Australian Patent Application No. 2002301502 (hide)

International Classifications

Event Publications

6 March 2003 Application Open to Public Inspection

Published as AU-A-2002301502

5 June 2003 Section 223 Application Allowed

St. Judes Pharmaceuticals, Inc. The time in which to make a further application for a divisional patent has been extended to 18.11.2002 . Address for service in Australia - PIZZEYS Level 14 ANZ Centre 324 Queen Street Brisbane QLD 4001

5 June 2003 Change of Name(s) of Applicant(s), Section 104

Texas Pharmaceuticals, Inc. The name of the applicant has been changed to St. Judes Pharmaceuticals, Inc.

17 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.